APO-VILAZODONE 10 MG
VILAZODONE HYDROCHLORIDE : 10 MG · DIN 02551810 · APOTEX INC
Health Canada status: MARKETED
What is APO-VILAZODONE?
APO-VILAZODONE 10 MG contains VILAZODONE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02551810, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 21-Feb-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-VILAZODONE used for?
APO-VILAZODONE (vilazodone hydrochloride tablets) is indicated for the symptomatic relief of Major Depressive Disorder (MDD). The short-term efficacy of vilazodone hydrochloride tablets was demonstrated in randomized, double-blind, placebo-controlled studies of 8 to 10-weeks.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02551810 |
|---|---|
| Brand name | APO-VILAZODONE |
| Generic / active ingredient | VILAZODONE HYDROCHLORIDE : 10 MG |
| Manufacturer | APOTEX INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AX24 VILAZODONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Feb-2025 |
How is it stored and handled?
null
How is it supplied?
Bottles of 30 tablets
What can be used instead?
Other Canadian products sharing ATC code N06AX24 VILAZODONE. 6 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-VILAZODONE | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02551829 |
| APO-VILAZODONE | 40 MG | TABLET | APOTEX INC | MARKETED | DIN 02551837 |
| VIIBRYD | 10 MG | TABLET | ABBVIE CORPORATION | MARKETED | DIN 02443724 |
| VIIBRYD | 20 MG | TABLET | ABBVIE CORPORATION | MARKETED | DIN 02443732 |
| VIIBRYD | 40 MG | TABLET | ABBVIE CORPORATION | MARKETED | DIN 02443740 |
| VIIBRYD | 10 MG | KIT ; TABLET | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02443759 |
| VIIBRYD | 10 MG | KIT ; TABLET | FOREST LABORATORIES CANADA INC | CANCELLED PRE MARKET | DIN 02443767 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.